Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > PDGFR > Tovetumab (Anti-PDGFRA / CD140a)

Tovetumab (Anti-PDGFRA / CD140a)

ChemLeader 95+%
Catalog No:CLA1336 CAS No.:1243266-04-7 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $800.00 Visible after login
- +
5 mg 3-5days $2300.00 Visible after login
- +
10 mg 3-5days $4200.00 Visible after login
- +
50 mg 3-5days $18500.00 Visible after login
- +
100 mg 3-5days $34000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Tovetumab (Anti-PDGFRA / CD140a)
CAS1243266-04-7
Storage condition Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Product details

Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays